edoxaban
Showing 1 - 25 of 208
Thrombosis, Venous, Cancer, Catheter Complications Trial in Beijing (Edoxaban)
Not yet recruiting
- Thrombosis, Venous
- +2 more
- Edoxaban
-
Beijing, Beijing, ChinaNational Cancer Center/National Clinical Research Center for Can
Nov 20, 2023
Liver Cirrhosis Trial (Apixaban 5 MG [Eliquis], Edoxaban 60 MG [Lixiana])
Not yet recruiting
- Liver Cirrhosis
- Apixaban 5 MG [Eliquis]
- Edoxaban 60 MG [Lixiana]
- (no location specified)
May 19, 2023
CTEPH Trial in Fukuoka (Edoxaban, Warfarin Potassium, Warfarin Potassium )
Active, not recruiting
- CTEPH
- Edoxaban
- +3 more
-
Fukuoka, JapanKyushu University Hospital
Aug 30, 2022
Anticoagulant Therapy Trial in Mannheim (Apixaban 5 MG Tab, Dabigatran 150 MG Tab, Edoxaban 60Mg Tab)
Active, not recruiting
- Anticoagulant Therapy
- Apixaban 5 MG Tab
- +3 more
-
Mannheim, GermanyClincial Research Serivces
Aug 4, 2022
Atrial Fibrillation Trial in Padova
Completed
- Atrial Fibrillation
-
Padova, ItalyPadua University Hospital
Aug 6, 2022
Non-Valvular Atrial Fibrillation Trial in Beijing (Edoxaban)
Recruiting
- Non-Valvular Atrial Fibrillation
- Edoxaban
-
Beijing, Beijing, ChinaFuwai Hospital, Chinese Academy of Medical Sciences
Jun 14, 2022
Routine Clinical Practice for Non-valvular Atrial Fibrillation
Completed
- Atrial Fibrillation
- Edoxaban
-
Hong Kong, Hong Kong
- +3 more
Aug 17, 2022
Determining Clinical Relevance of Interaction Between
Recruiting
- Drug-drug Interaction
- Blood sampling - Pharmacokinetic assessment
-
Nijmegen, Netherlands
- +2 more
Oct 26, 2022
Mitral Valve Stenosis, Atrial Fibrillation, Stroke Trial in Korea, Republic of (Edoxaban, Warfarin)
Recruiting
- Mitral Valve Stenosis
- +3 more
- Edoxaban
- Warfarin
-
Seoul, Seocho-gu, Korea, Republic of
- +6 more
Sep 12, 2022
Venous Thrombosis, Tumors, Anticoagulant Trial in Kyoto (12-month Edoxaban, 3-month Edoxaban)
Active, not recruiting
- Venous Thrombosis
- +2 more
- 12-month Edoxaban
- 3-month Edoxaban
-
Kyoto, JapanDepartment of Cardiovascular Medicine, Kyoto University Graduate
Aug 16, 2022
Routine Clinical Practice for Non-Valvular Atrial Fibrillation
Completed
- Atrial Fibrillation
- Edoxaban
-
Khon Kaen, Muang District, Thailand
- +5 more
May 5, 2022
Covid19 Trial in Germany (Anticoagulation Agents (Edoxaban and/or high dose LMWH), Low dose Low molecular weight heparin or
Recruiting
- Covid19
- Anticoagulation Agents (Edoxaban and/or high dose LMWH)
- Low dose Low molecular weight heparin or Placebo
-
Aachen, Germany
- +9 more
May 16, 2022
Ischemic Stroke, Atrial Fibrillation, Hemorrhagic Transformation Stroke Trial in Edmonton (Edoxaban 60 MG, Edoxaban 30 mg)
Recruiting
- Ischemic Stroke
- +2 more
- Edoxaban 60 MG
- Edoxaban 30 mg
-
Edmonton, Alberta, CanadaUniversity of Alberta
Apr 6, 2022
Atrial Fibrillation and Flutter, Valvular Heart Disease Trial in Canada (Edoxaban Pill)
Recruiting
- Atrial Fibrillation and Flutter
- Valvular Heart Disease
- Edoxaban Pill
-
Granby, Quebec, Canada
- +7 more
Feb 2, 2022
SCAD, AMI Trial in Sao Paulo (ASA, Clopidogrel, Edoxaban)
Recruiting
- SCAD
- AMI
- ASA
- +2 more
-
Sao Paulo, BrazilInstituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Fac
Nov 4, 2021
Ischemic Stroke, Anticoagulant Adverse Reaction Trial in Taipei (Dabigatran, rivaroxaban, apixaban, edoxaban)
Recruiting
- Ischemic Stroke
- Anticoagulant Adverse Reaction
- Dabigatran, rivaroxaban, apixaban, edoxaban
-
Taipei, TaiwanNational Taiwan University Hospital
Nov 22, 2023
Auricular Fibrillation Trial in Spain (Edoxaban)
Recruiting
- Auricular Fibrillation
- Edoxaban
-
Elche, Alicante, Spain
- +32 more
Feb 16, 2023
Anticoagulation in Venous Thromboembolism and Cancer
Active, not recruiting
- Neoplasms
- Embolism
- Apixaban
- +5 more
-
London, United KingdomPfizer Investigational Site
Nov 17, 2022
Edoxaban in Patients 80 Years of Age or Older With Nonvalvular
Recruiting
- Atrial Fibrillation
- Edoxaban
-
Ansan, Korea, Republic of
- +29 more
Apr 6, 2023
Atrial Fibrillation, Left Atrial Appendage Thrombosis Trial in Korea, Republic of (Edoxaban)
Recruiting
- Atrial Fibrillation
- Left Atrial Appendage Thrombosis
- Edoxaban
-
Daegu, Korea, Republic of
- +11 more
Mar 12, 2022
Healthy Trial (Tegoprazan 50mg, Edoxaban 60mg, Apixaban 5mg)
Not yet recruiting
- Healthy
- Tegoprazan 50mg
- +3 more
- (no location specified)
Feb 2, 2023
Atrial Fibrillation, Recurrent Venous Thromboembolism Trial in Barcelona (dabigatran, rivaroxaban, apixaban or edoxaban)
Recruiting
- Atrial Fibrillation
- Recurrent Venous Thromboembolism
- dabigatran, rivaroxaban, apixaban or edoxaban
-
Barcelona, Catalonia, SpainHospital de la Santa Creu i Sant Pau
Apr 27, 2022
Anticoagulation Length of ThErapy and Risk of New Adverse evenTs
Completed
- Venous Thromboembolism
- Anticoagulants and Bleeding Disorders
- Oral Anticoagulant
-
Oakland, California
- +1 more
Oct 31, 2022
Oral Anti-coagulants in Fragile Percutaneous Endoscopic
Completed
- Atrial Fibrillation
- Edoxaban
-
Rome, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Oct 25, 2021